Go Pro
OTCMKTS:ABMC

American Bio Medica (ABMC) Stock Price, News & Analysis

American Bio Medica logo

About American Bio Medica Stock (OTCMKTS:ABMC)

Key Stats

Today's Range
N/A
50-Day Range
N/A
52-Week Range
N/A
Volume
N/A
Average Volume
N/A
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

American Bio Medica Corporation is a biopharmaceutical company headquartered in West Palm Beach, Florida, focused on the development and commercialization of therapeutics for neurodegenerative diseases. The company’s research pipeline comprises small-molecule and biologic candidates designed to address cognitive impairment, vascular dementia and Parkinson’s disease by targeting disease-specific pathways. Through preclinical models and early-phase clinical trials, ABMC seeks to advance its lead compounds toward proof-of-concept and regulatory milestones.

In addition to its proprietary drug development programs, ABMC operates a wholly owned subsidiary, Food and Drug Sciences, Inc., which provides contract research services. This subsidiary performs GLP-compliant toxicology, pharmacology and regulatory consulting for pharmaceutical, biotechnology and medical device clients. By offering comprehensive safety assessments and guidance on regulatory submissions, Food and Drug Sciences generates supplemental revenue while reinforcing ABMC’s in-house development expertise.

Serving customers primarily across the United States, American Bio Medica leverages its integrated research and CRO capabilities to move product candidates from discovery through early clinical evaluation. The company’s leadership team brings experience in clinical development, toxicology and regulatory affairs, positioning ABMC to pursue strategic partnerships and licensing opportunities that can drive growth and facilitate the transition of its pipeline assets toward commercialization.

AI Generated. May Contain Errors.

Receive ABMC Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for American Bio Medica and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

ABMC Stock News Headlines

American Bio Medica Corp. (ABMC)
American Bio Medica Corp
Ticker Revealed: Pre-IPO Access to "Next Elon Musk" Company
We’ve found The Next Elon Musk… and what we believe to be the next Tesla. It’s already racked up $26 billion in government contracts. Peter Thiel just bet $1 Billion on it.tc pixel
American Bio Medica Corp.
American Bio Medica Corporation (ABMC)
Specimen Validity Testing Market Research, 2023-2030
See More Headlines

ABMC Stock Analysis - Frequently Asked Questions

American Bio Medica Corp. (OTCMKTS:ABMC) posted its quarterly earnings results on Monday, May, 14th. The company reported ($0.01) earnings per share for the quarter. The company earned $1.04 million during the quarter.

Shares of ABMC stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that American Bio Medica investors own include FuelCell Energy (FCEL), OPKO Health (OPK), Canadian Western Bank (CWB), Canopy Growth (CGC), Newmont (NEM), Cortex Pharmaceuticals (RSPI) and V Group (VGID).

Company Calendar

Last Earnings
5/14/2018
Today
8/05/2026
Fiscal Year End
12/31/2026

Industry, Sector and Symbol

Stock Exchange
OTCMKTS
Industry
Healthcare Equipment & Supplies
Sub-Industry
N/A
Current Symbol
OTCMKTS:ABMC
CIK
896747
Employees
30
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
N/A
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
N/A
Return on Assets
N/A

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
N/A
Quick Ratio
N/A

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
N/A
Price / Book
N/A

Miscellaneous

Outstanding Shares
N/A
Free Float
N/A
Market Cap
N/A
Optionable
Not Optionable
Beta
N/A
7 Best Space Stocks to Own in 2026 Cover

The space race is growing fast, and you don’t have to have gotten in early on SpaceX to profit. This report shows seven space stocks you can buy today that may grow as rockets, satellites, defense, space internet, and new space technology become more important.

Get This Free Report

This page (OTCMKTS:ABMC) was last updated on 8/5/2026 by MarketBeat.com Staff.
From Our Partners